Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort by Kucharska-Newton, Anna M. et al.
© The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. 
For permissions, please e-mail: journals.permissions@oup.com.
382
Journals of Gerontology: Medical Sciences
cite as: J Gerontol A Biol Sci Med Sci, 2017, Vol. 72, No. 3, 382–388
doi:10.1093/gerona/glw144
Advance Access publication July 28, 2016
Research Article
Operationalizing Frailty in the Atherosclerosis Risk in 
Communities Study Cohort
Anna M.  Kucharska-Newton,1,* Priya  Palta,1,* Sheila  Burgard,2 Michael E.  Griswold,3 
Jennifer L. Lund,1 Benjamin D. Capistrant,4 Stephen B. Kritchevsky,5 Karen Bandeen-Roche,6 
and B. Gwen Windham3 
1Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill. 2Collaborative Studies 
Coordinating Center, Department of Biostatistics, University of North Carolina Gillings School of Global Public Health, Chapel Hill. 
3Department of Medicine, University of Mississippi Medical Center, Jackson. 4Division of Epidemiology and Community Health, University 
of Minnesota, Minneapolis. 5Division of Gerontology and Geriatric Medicine, Department of Medicine, Wake Forest University, Winston-
Salem, North Carolina. 6Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
*These authors contributed equally to this work.
Address correspondence to Priya Palta, PhD, MHS, Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 
137 E. Franklin Street, Suite 306, Chapel Hill, NC 27514. E-mail: priya_palta@unc.edu
Received March 9, 2016; Accepted July 8, 2016
Decision Editor: Dr. James Goodwin, MD
Abstract
Background: Factors that may contribute to the development of frailty in late life have not been widely investigated. The Atherosclerosis Risk 
in Communities (ARIC) Study cohort presents an opportunity to examine relationships of midlife risk factors with frailty in late life. However, 
we first present findings on the validation of an established frailty phenotype in this predominantly biracial population of older adults.
Methods: Among 6,080 participants, we defined frailty based upon the Cardiovascular Health Study (CHS) criteria incorporating measures 
of weight loss, exhaustion, slow walking speed, low physical activity, and low grip strength. Criterion and predictive validity of the frailty 
phenotype were estimated from associations between frailty status and participants’ physical and mental health status, physiologic markers, 
and incident clinical outcomes.
Results: A total of 393 (6.5%) participants were classified as frail and 50.4% pre-frail, similar to CHS (6.9% frail, 46.6% pre-frail). In age-
adjusted analyses, frailty was concurrently associated with depressive symptoms, low self-rated health, low medication adherence, and clinical 
biomarker levels (ie, cholesterol, hemoglobin A1c, white blood cell count, C-reactive protein, and hemoglobin). During 1-year follow-up, 
frailty was associated with falls, low physical ability, fatigue, and mortality.
Conclusions: These findings support the validity of the CHS frailty phenotype in the ARIC Study cohort. Future studies in ARIC may elucidate 
early-life exposures that contribute to late-life frailty.
Keywords: Frailty—Epidemiology—Cohort study
Frailty is a clinical syndrome characterized by vulnerability to 
adverse health outcomes resulting from decreased reserve and low 
resistance to stressors. The co-occurrence of multisystem, age-asso-
ciated declines is the impetus for identifying frailty as a syndrome 
that includes weight loss, weakness, exhaustion, decreased physi-
cal activity, and slowness (1). Frailty is associated with a number 
of adverse outcomes, including hospitalizations (2) and cognitive 
impairment (3–5), yet little is known about risk factors in midlife, 
when interventions may be more effective, on risk of frailty onset 
in late life. The 25 plus years of follow-up in the Atherosclerosis 
Risk in Communities (ARIC) Study cohort present an opportunity 
to elucidate the association of early-life risk factors for frailty in a 
biracial population. Using the frailty phenotype definition, derived 
from the Cardiovascular Health Study (CHS) (1), our aim is to 
develop a frailty phenotype within the ARIC Study cohort, provide 
estimates of the prevalence of frail, pre-frail, and robust states of 
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ARIC participants, and therefore lay the groundwork for future 
assessments of the etiology of frailty.
Methods
Study Population
The ARIC cohort was established in 1987 as a probability sample 
of 15,792 men and women, aged 45–64 years (mean age: 54 years), 
from four US communities. Extensive physical examinations were 
performed at baseline and at four subsequent clinic visits. Ongoing 
follow-up is conducted through annual telephone interviews and 
surveillance of mortality and cardiovascular morbidity. The current 
study uses data from the fifth examination, when objective meas-
ures of frailty were first assessed (Visit 5, 2011–2013; n = 6,538). 
Prevalent medical conditions at Visit 5 were ascertained from 
self-report, prior hospitalizations, and Visit 5 physical examina-
tion. Black participants from Washington County, Maryland and 
Minneapolis, Minnesota (n = 25), and participants reporting Asian 
or American Indian/Alaskan Indian ethnicity (n = 18) were excluded 
due to small numbers.
Frailty Phenotype
The CHS frailty components were operationalized in ARIC (Table 1) 
with some modifications as required by available data and incorpo-
rating methods used in previous studies. Weight loss was defined as 
10% of weight lost from Visit 4 (1996–1999) to Visit 5 (2011–2013) 
or Visit 5 body mass index (BMI) less than 18.5 kg/m2 (6). The modi-
fied Baecke questionnaire assessed physical activity (7), with low 
physical activity defined as the lowest 20th percentile. Walking speed 
was measured at participants’ usual pace over 4 m. Slow walking 
speed was defined using gender- and height-adjusted thresholds from 
the CHS cohort. Participants who responded “some of the time” or 
“most of the time” to either of the following two questions from the 
Center for Epidemiological Studies-Depression (CES-D) scale (8), “I 
felt everything I  did was an effort” and “I could not get ‘going’,” 
were classified as having exhaustion. Grip strength was assessed in 
the participant’s preferred hand using an adjustable, hydraulic grip 
strength dynamometer. Excluded were participants who had bilat-
eral surgery in the hands or wrists in the previous 3 months. Low 
grip strength was defined as gender- and BMI-specific grip strength 
in the lowest 20th percentile based on established norms (1).
The composite frailty variable was categorized as robust when 
no frailty components were present; pre-frail, if one or two of the 
components were present; and frail, if three or more of the compo-
nent phenotypes were present. Participants with missing information 
on all component characteristics were classified as missing the frailty 
phenotype (n = 415, 6.4%), yielding an analytic sample of 6,080. In 
a sensitivity analysis, we assigned a frailty category for participants 
who were missing the frailty phenotype (n = 415), but who had at 
least one criterion component nonmissing. This was performed using 
the most prevalent frailty classification observed for the nonmiss-
ing criterion among those with a frailty classification (n = 6,080). 
For example, frailty of a participant with low grip strength, and all 
other component characteristics missing, was defined as the most 
prevalent frailty category observed among participants who had 
both nonmissing frailty phenotype and nonmissing low grip strength 
(Supplementary Table  3). Participants with two nonmissing com-
ponent characteristics, such as slow walking speed and low grip 
strength, were therefore classified according to the most prevalent 
frailty category observed among participants who had a nonmissing 
frailty phenotype, nonmissing slow walking speed, and nonmissing 
low grip strength (Supplementary Table 4).
Outcomes
Criterion validity
We defined criterion validity of the frailty phenotype as concurrent 
presence of selected phenotypes signifying participant’s health sta-
tus. In cross-sectional analyses, we examined the association of the 
frailty phenotype with prevalence of low and fair self-rated health 
(SRH), physical and mental health status assessed from the SF-12 
Table 1. Operationalization of the Frailty Construct in ARIC Cohort in Comparison With the CHS and WHAS
Characteristics of Frailty ARIC (N = 6,080) CHS (N = 5,317)
Weight loss 10% of weight lost from V4 (1996–1999) to V5  
(2011–2013) or BMI < 18.5 at Visit 5
20.1% Lost > 10 lbs in last year 6.0%
Low physical activity Gender-specific 20th percentile rank of the Baecke leisure 
sports activity index
14.7% 270 on an activity scale (18 
items)
22.0%
Slow walking speed Gender- and height-adjusted time in seconds used to  
walk 4 m
Slowest speed defined as the 20th percentile of the 
distribution
15.1% Walking 15 ft:
Time ≥ 7 for height ≤ 
159 cm
Time ≥ 6 for height > 
159 cm
20.0%
Exhaustion Responded “some of the time” or “most of the time” to 
the following questions: I felt everything I did was an 
effort or I could not get “going”
10.4% Responded “some of the 
time” or “most of the time” 
to the following questions: 
I felt everything I did was 
an effort or I could not get 
“going”
17.0%
Low grip strength Gender- and BMI-specific grip strength in the lowest 20% 
percentile of distributions
25.4% BMI Grip strength 20.0%
≤23 ≤17
23.1–26 ≤17.3
26.1–29 ≤18
>29 ≤21
Frailty n = 393 (6.5%) n = 368 (6.9%)
Notes: ARIC = Atherosclerosis Risk in Communities; BMI = body mass index; CHS = Cardiovascular Health Study; WHAS = Women’s Health and Aging Study.
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questionnaire (9), medication adherence, and multimorbidity (the 
presence of at least two chronic diseases). We also compared levels 
of clinical biomarkers (ie, white blood cell count (10), total cho-
lesterol (11), hemoglobin (12), hemoglobin A1c [HbA1c] (13), and 
C-reactive protein [CRP (10)]) previously associated with frailty, 
across the frailty phenotypes.
Predictive validity
We examined the association of the frailty phenotype with the fol-
lowing outcomes assessed within 1  year of Visit 5: fatigue, falls, 
physical ability, and mortality.
Outcomes ascertainment
Disease status was ascertained at baseline through questionnaires 
administered to the participants, medical record abstraction prior to 
Visit 5, and from self-report of physician’s diagnoses obtained during 
annual telephone interviews prior to Visit 5. High medication adher-
ence was defined as a score ≥2 on the four-item Morisky Medication 
Adherence Measure (14). Participants’ SRH was reported as “excel-
lent,” “very good,” “good,” “fair,” or “poor.” Scores for the physical 
and mental domains were obtained as T-scores standardized to the 
average US general population according to standard protocols (9). 
Participants’ cognitive status at Visit 5 was assessed using the Mini-
Mental State Examination (MMSE) test (15).
Fatigue was assessed using a custom questionnaire based on the 
PROMIS adult bank of fatigue questions during a telephone fol-
low-up interview conducted approximately 1  year following Visit 
5. Responses were scored using item-level calibration with standardi-
zation to the average US general population (16) (see Supplementary 
Material).
Within 1 year of Visit 5, ARIC participants were asked if in the 
previous 6 months they had experienced a fall and if so, how many. 
Physical ability was assessed as self-reported “difficulty in perform-
ing” household activities, meal preparation, self-care, and manage-
ment of finances (17–19).
Mortality was ascertained from CMS Medicare data using the 
Medicare Beneficiary Summary Files for the years 2011–2013 that 
were linked to the ARIC Study cohort for 6,422 cohort partici-
pants (98.9%) enrolled in CMS Medicare at the time of Visit 5 (20). 
To ensure at least 1  year of follow-up in mortality estimates, we 
excluded from the assessment of mortality participants whose Visit 
5 examination occurred during 2013 (n = 909).
Statistical Analysis
Baseline demographic and health characteristics were described by 
frailty status. Age was centered at the sample population median 
(75 years). Generalized linear models were used to estimate the age-
adjusted cross-sectional associations between frailty status and clini-
cal characteristics to quantify criterion and predictive validity. Cox 
proportional hazard models, adjusted for age, demographics, and 
comorbidities were fit to estimate mortality across frailty groups.
Results
The distribution of the frailty-defining criteria in ARIC compared 
with CHS is presented in Table  1. Low grip strength and weight 
loss were the most prevalent component characteristics (25.4% and 
20.1%, respectively). Exhaustion was least prevalent, at 10.4%. 
Among the 6,080 ARIC participants at Visit 5, 393 (6.5%) were 
frail, 3,066 (50.4%) were pre-frail, and 2,621 (43.1%) were robust 
(Table 2). Frail and pre-frail participants were more likely to be older, 
of black race, report fair or poor SRH, have a higher prevalence of 
cardiovascular diseases, and report more chronic conditions com-
pared with their robust counterparts. An increasing proportion of 
participants with chronic diseases other than cancer were observed 
in frail compared with pre-frail and robust participants. The aver-
age BMI increased from 28.3 kg/m2 (standard deviation [SD]: 5.0) 
among the robust, to 28.9 kg/m2 (SD: 5.9) among the pre-frail, to 
29.7 kg/m2 (SD: 7.1) among the frail. Depressive symptomology 
using the CES-D score also increased across the frailty categories. 
The prevalence of frailty increased with age and was significantly 
higher in women compared with men (Table 3).
Criterion Validity
In age-adjusted analyses, the proportion of participants with mul-
timorbidity was lowest among robust and highest among frail par-
ticipants (49.0% vs 75.1%; Table 4). The proportion of participants 
with good/excellent SRH decreased from 66.6% among the robust, 
to 25.8% among frail participants. The SF-12 physical and men-
tal health aggregate scores, MMSE, and CES-D scores suggest that 
physical and mental health was better among robust participants 
than pre-frail participants, which in turn was better than that of 
frail participants. Frail participants also used more medications than 
robust participants (10.7 vs 8.6; Table 4). The proportion of partici-
pants with high medication adherence was lowest among the frail.
Predictive Validity
Participants classified as frail reported falls more frequently than did 
those classified as pre-frail and robust (25.0%, 16.1%, and 12.5%, 
respectively; Table 5). Frail participants were more likely to report 
limitations in physical ability (eg, meal preparation and self-care). 
Management of finances was not associated with frailty status. Frail 
participants reported a greater level of fatigue at approximately 
1  year following assessment of frailty than robust participants. 
Sensitivity analyses, limited to those with at least 180 days of follow-
up, yielded estimates similar to those observed in overall analyses. 
Mortality increased across frailty categories for both gender and 
race subgroups (Figure 1).
We observed few gender and race differences in outcomes across 
the frailty phenotype (Supplementary Table  1). Most notable was 
poorer SRH observed among women as compared with men. SRH 
was also significantly higher among whites than blacks; however, 
change in SRH across frailty categories did not differ by race. The 
overall proportion of those with multimorbidity, which was greater 
among blacks compared with whites, did not change appreciably 
across frailty categories.
Sensitivity Analyses
Analyses conducted using the definition of frailty that minimized 
the amount of participants with missing frailty classification yielded 
estimates of concurrent and predictive validity that were similar to 
those obtained using the original frailty construct (data not shown). 
The definition of frailty created within ARIC was therefore robust to 
approximately 6.4% of data missingness.
Discussion
In this study, we validated a version of the CHS frailty pheno-
type, modified to data available in a biracial older population of 
ARIC Study cohort participants, and demonstrated nearly identical 
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prevalence rates of frailty in the ARIC Study cohort as was reported 
among CHS participants 15 years earlier. We anticipate the frailty 
assessment in the ARIC cohort will provide unique opportunities 
to shed light on important contributors to late-life frailty. Although 
most studies on the frailty syndrome have been conducted in older 
adults, ARIC provides a detailed characterization of this cohort 
since midlife. Consistent with other studies, the prevalence of frailty 
was higher among older participants, women, and blacks. Low grip 
strength was the most prevalent frailty component, followed by 
weight loss and slowness. The frailty phenotype, originally devel-
oped in the CHS cohort (1), has been previously validated (1,2,21) 
but requires further validation in several distinct populations to 
determine its utility in predicting the risk of long-term adverse health 
outcomes. The frailty phenotype was validated in the present study 
by examining its associations with clinical characteristics and physi-
ological markers previously found to be associated with frailty.
In age-adjusted cross-sectional analyses, frailty was associated 
with presence of depressive symptoms, low SRH, comorbidity bur-
den, low medication adherence, and clinical biomarker levels (ie, 
total cholesterol, HbA1c, white blood cell count, C-reactive protein, 
and hemoglobin). Across all frailty phenotypes, blacks reported 
lower SRH than whites. There is extensive literature to suggest that 
SRH is an important predictor of adverse health outcomes, including 
coronary heart disease (22) and mortality (23). These observed racial 
differences in SRH may be attributable to access to health care (24) 
and may contribute to observed differences in frailty prevalence by 
race subgroups.
Predictive validity of the frailty phenotype was demonstrated 
through associations with participant’s ability to perform func-
tional tasks, including housekeeping, meal preparation, and self-care 
within 1  year of frailty assessment. In a critical test of predictive 
validity, frailty in ARIC was observed to be associated with a higher 
risk of mortality that did not differ by gender or race.
Our findings were similar to observations from other popula-
tion-based cohorts of older adults, underscoring the utility of the 
CHS definition of frailty in ARIC. Compared with the Women’s 
Health and Aging Study (WHAS) (6), a population-based observa-
tional cohort of older women, we observed a lower prevalence of 
frailty in ARIC women (11.3% vs 6.5%); this could be explained 
by WHAS sampling, which included a broader representation of the 
Table 2. Baseline Demographic and Health Characteristics; the ARIC Study 2011–2013
Characteristic Overall Robust Pre-Frail Frail p Value
N 6,080 (100%) 2,621 (43.1%) 3,066 (50.4%) 393 (6.5%)
Age, y <.001
 66–74 2,887 (47.5) 1,536 (58.6) 1,230 (40.1) 121 (30.8)
 75–84 2,786 (45.8) 1,016 (38.8) 1,558 (50.8) 212 (53.9)
 85+ 407 (6.7) 69 (2.6) 278 (9.1) 60 (15.3)
Gender, % male 2,526 (41.5) 1,195 (45.6) 1,198 (39.1) 133 (33.8) <.001
Race, % black 1,383 (22.7) 508 (19.4) 776 (25.3) 99 (25.2) <.001
ARIC Study center <.001
 Forsyth 1,300 (21.4) 535 (20.4) 679 (22.1) 86 (21.9)
 Jackson 1,287 (21.2) 484 (18.5) 713 (23.3) 90 (22.9)
 Minneapolis 1,819 (29.9) 919 (35.1) 821 (26.8) 79 (20.1)
 Washington County 1,674 (27.5) 683 (26.1) 853 (27.8) 138 (35.1)
Self-rated health <.001
 Excellent 986 (16.3) 604 (23.1) 366 (12.1) 16 (4.1)
 Very good 2,216 (36.7) 1,139 (43.5) 992 (32.8) 85 (21.7)
 Good 2,091 (34.6) 741 (28.3) 1,190 (39.3) 160 (40.8)
 Fair 676 (11.2) 131 (5.0) 435 (14.4) 110 (28.1)
 Poor 71 (1.2) 4 (0.2) 46 (1.5) 21 (5.4)
Prevalent disease
 CHD 893 (14.9) 309 (12.0) 508 (16.9) 76 (19.7) <.001
 Heart failure 991 (16.3) 294 (11.2) 564 (18.4) 133 (33.8) <.001
 Stroke 235 (3.9) 56 (2.1) 148 (4.8) 31 (7.9) <.001
 Atrial fibrillation 453 (7.5) 134 (5.1) 266 (8.7) 53 (13.5) <.001
 Diabetes 1,973 (33.1) 673 (25.9) 1,124 (37.9) 176 (45.1) <.001
 Hypertension 4,472 (74.4) 1,827 (70.2) 2,330 (77.1) 315 (81.8) <.001
 Arthritis 2,599 (42.7) 1,031 (39.3) 1,352 (44.1) 216 (55.0) <.001
 Cancer 197 (3.2) 75 (2.9) 110 (3.6) 12 (3.1) .30
Number of chronic conditions <.001
 0 670 (11.0) 379 (14.5) 278 (9.1) 13 (3.3)
 1 1,930 (31.7) 957 (36.5) 888 (29.0) 85 (21.6)
 2 2,129 (35.0) 859 (32.8) 1,123 (36.6) 147 (37.4)
 3–4 1,286 (21.1) 417 (15.9) 735 (24.0) 134 (34.1)
 ≥5 65 (1.0) 9 (0.3) 42 (1.4) 14 (3.6)
Ever-drinker 4,633 (78.7) 2,138 (82.5) 2,211 (76.2) 284 (72.4) <.001
Ever-smoker 3,310 (58.8) 1,408 (58.0) 1,692 (60.0) 210 (55.1) .11
BMI, mean (SD) 28.6 (5.7) 28.3 (5.0) 28.9 (6.1) 29.7 (7.1) <.001
CES-D, median (IQR) 2 (1, 5) 2 (1, 3) 3 (1, 5) 4 (2, 8) <.001
Notes: ARIC = Atherosclerosis Risk in Communities; BMI = body mass index; CES-D = Center for Epidemiological Studies-Depression; CHD = coronary heart 
disease; IQR = interquartile range; SD = standard deviation.
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disabled through targeted recruitment and lower susceptibility to 
healthy volunteer effects. It is also important to note that WHAS 
participants were all women, who are at a higher risk of disabil-
ity compared with men (25). Compared with the Women’s Health 
Initiative (WHI) (2), a prospective study of women aged 50–79, 
the prevalence of frailty in ARIC was also lower (16.3% vs 6.5%). 
The prevalence of frailty in the National Health and Aging Trends 
Study (NHATS) was similar to that of WHI (15%), which is higher 
than that of ARIC (6.5%). Similar to ARIC, frailty in NHATS was 
more prevalent among individuals of older ages, women, and racial/
ethnic minorities; however, NHATS reported a higher incidence of 
falls among the frail (21). Differences across these cohorts are to 
be expected considering the distinct component measures that may 
not be identical to those in CHS. However, similar estimates of the 
prevalence of frailty in CHS and ARIC and associations with health 
status, incident outcomes, and biomarkers, despite heterogeneity in 
some measurements, age cohorts, and geographical catchment areas, 
support the validity of the frailty construct.
The role of multimorbidity in the etiology of frailty remains 
unclear, with some studies supporting the accumulation of deficits 
as a reliable marker of the frailty construct (26), while others sug-
gesting comorbidity, disability, and frailty overlap (27), but are dis-
tinct constructs. Prior data from WHAS suggest increased risk of 
frailty with a higher number of dysregulated physiologic patterns 
(28). In WHI and CHS, the prevalence of greater chronic condi-
tions increased across frailty categories as the number of chronic 
diseases reached ≥3. In ARIC, 75% of frail participants had two or 
more chronic conditions; however, the prevalence of multimorbidity 
across the frailty groups differed by only 1%–2%, supporting the 
observation that frailty overlaps with, but is not fully explained by 
chronic disease (27).
Strengths and Limitations
The informative ARIC cohort is a large study of older adult men and 
women, allowing for assessment of gender and racial differences in 
the prevalence of frailty. The availability of data since midlife (29) is 
unique and may elucidate important factors associated with frailty 
in late life. Many of the other larger cohorts have been primarily in 
older women (2,6) with small proportions of blacks (1) and could 
not adequately examine frailty by clinically and socially meaningful 
subgroups.
Validity and reliability of the multifactorial frailty construct rely 
on the strengths and weaknesses of its components. These component 
characteristics in the ARIC cohort were highly correlated (data not 
shown). Frailty components derived from self-report (ie, exhaustion, 
low physical activity) are subject to lower reliability compared with 
that of the objectively measured components (ie, walking speed). 
Our measure of weight loss, estimating 10% weight lost during the 
Table  4. Baseline Cross-Sectional Association of the Frailty Phenotype With Study Participant Characteristics; the ARIC Study Cohort 
2011–2013
Characteristic Robust (n = 2,621) Pre-Frail (n = 3,066) Frail (n = 393)
Overall
 Self-rated health, % good or excellent (95% CI) 66.6 (64.7, 68.4) 44.8 (43.1, 46.6)* 25.8 (21.0, 30.5)*
 SF-12 physical aggregate score (SD) 49.9 (0.6) 44.2 (0.7)* 36.4 (0.7)*
 SF-12 mental aggregate score (SD) 56.3 (0.1) 54.8 (0.1)* 52.1 (0.1)*
 MMSE (SD) 28.0 (0.5) 27.0 (0.6)* 26.3 (0.6)*
 CES-D (SD) 2.4 (0.1) 3.6 (0.1)* 5.3 (0.1)*
 % with >2 chronic conditions (95% CI) 49.0 (47.2, 50.1) 62.0 (60.2, 63.7)* 75.1 (70.2, 79.9)*
 Total cholesterol, mmol/L (SD) 4.8 (0.1) 4.7 (0.07) 4.5 (0.1)*
 White blood cell count, mg/L (SD) 5.7 (0.1) 6.1 (0.1)* 6.5 (0.1)*
 CRP, mg/L (SD) 3.5 (0.3) 4.6 (0.4)* 5.9 (0.4)*
 HbA1c, % (95% CI) 5.7 (0.1) 6.1 (0.1)* 6.1 (0.1)*
 Hemoglobin, g/dL (SD) 13.6 (0.1) 13.1 (0.1)* 12.7 (0.1)*
 Self-reported number of medications used (SD) 8.6 (0.02) 9.8 (0.02)* 10.7 (0.02)*
 Medication adherence, % high (95% CI) 62.5 (60.6, 64.4) 58.5 (56.8, 60.3) 57.4 (53.6, 62.2)*
Notes: All analyses adjusted for age centered at the sample population median (75 y). ARIC = Atherosclerosis Risk in Communities; CES-D = Center for 
Epidemiological Studies-Depression; CI = confidence interval; CRP = C-reactive protein; HbA1c = hemoglobin A1c; MMSE = Mini-Mental State Examination; 
SD = standard deviation.
*p < .05 for significant difference compared to robust (referent group).
Table 3. Prevalence of Frailty in the ARIC Cohort, by Age and Race/
Gender Subgroups
Race/Gender 
Subgroups All Ages
Age Strata (y)
66–74 75–84 85+
Total cohort
 Total cohort n = 6,080 n = 2,887 n = 2,786 n = 407
  n (% frail) 393 (6.5) 121 (4.2) 212 (7.6) 60 (14.7)
 Total women n = 3,554* n = 1,737* n = 1,590* n = 227
  n (% frail) 260 (7.3) 89 (5.1) 139 (8.7) 32 (14.1)
 Total men n = 2,526 n = 1,150 n = 1,196 n = 180
  n (% frail) 133 (5.3) 32 (2.8) 73 (6.1) 28 (15.6)
Whites only
 Total whites n = 4,697 n = 2,129 n = 2,245 n = 323
  n (% frail) 294 (6.3) 85 (4.0) 159 (7.1) 50 (15.5)
 White women n = 2,623† n = 1,232† n = 1,221† n = 170
  n (% frail) 190 (7.2) 62 (5.0) 102 (8.4) 26 (15.3)
 White men n = 2,074 n = 897 n = 1,024 n = 153
  n (% frail) 104 (5.0) 23 (2.6) 57 (5.6) 24 (15.7)
Blacks only
 Total blacks n = 1,383 n = 758 n = 541 n = 84
  n (% frail) 99 (7.2) 36 (4.7) 53 (9.8) 10 (11.9)
 Black women n = 931 n = 505 n = 369 n = 57
  n (% frail) 70 (7.5) 27 (5.3) 37 (10.0) 6 (10.5)
 Black men n = 452 n = 253 n = 172 n = 27
  n (% frail) 29 (6.4) 9 (3.6) 16 (9.3) 4 (14.8)
Notes: ARIC = Atherosclerosis Risk in Communities.
*p < .05 for significant difference between women and men.
†p < .05 for significant difference between white women and white men.
D
ow
nloaded from
 https://academ
ic.oup.com
/biom
edgerontology/article-abstract/72/3/382/2630048 by U
niversity of N
orth C
arolina at C
hapel H
ill user on 17 August 2019
Journals of Gerontology: MEDICAL SCIENCES, 2017, Vol. 72, No. 3 387
almost 15 years between ARIC Visits 4 and 5, did not capture the 
“unintentional” weight loss. Similarly to WHAS, ARIC participants 
were also categorized as having significant weight loss if their BMI 
was less than 18.5 kg/m2. Our definition of low physical activity was 
based on the Baecke questionnaire and its comparison with physical 
activity assessments in CHS, WHAS, and WHI is not known. Despite 
these differences, the frailty measure in ARIC appears quite robust. 
Across the three frailty categories, missingness was low (<4%) for 
all variables examined with respect to criterion and predictive valid-
ity, except medication use, the missingness of which was 6% among 
the pre-frail and 5.6% among the frail. Using factor analyses, we 
confirmed the loading of the five frailty component variables onto 
one factor, suggesting that correlations between component criteria 
did not bias our assessment of the criterion and predictive validity 
of the frailty construct.
In summary, based on extant literature on the conceptualization 
of frailty across several cohorts, we concluded that this phenotype 
is stable across different study populations, the utility of the frailty 
construct is high, and it can be used to predict the risk of adverse 
health outcomes (30). As a result, it has strong potential to assist 
with risk stratification in the clinical setting. As an important ele-
ment of aging, future work may consider adding measures of cogni-
tive and social function to the frailty definition.
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